NCT02130271View on ClinicalTrials.gov

PET/MRI Imaging of Neuraxial Inflammation in Sciatica Patients

CompletedOBSERVATIONAL
Enrollment

42

Participants

Timeline

Start Date

April 30, 2014

Primary Completion Date

December 31, 2016

Study Completion Date

December 31, 2018

Conditions
Sciatica
Interventions
DRUG

Radioactive dye

The radioactive dye \[11C\]PBR28 will be administered through an intravenous line (IV).

RADIATION

PET/MRI

All subjects will undergo a simultaneous PET/MRI scan. The scan will be up to 2 hours long.

OTHER

Blood draw

Up to 11 tablespoons of blood will be drawn through an intravenous line (IV-line) for two purposes: 1) testing for the subject's genetic affinity to the radioactive dye, and 2) testing for the presence inflammatory biomarkers.

Trial Locations (1)

02114

MGH Center for Translational Pain Research, Boston

All Listed Sponsors
lead

Massachusetts General Hospital

OTHER

NCT02130271 - PET/MRI Imaging of Neuraxial Inflammation in Sciatica Patients | Biotech Hunter | Biotech Hunter